Cargando…
Long-Term CD4(+) T-Cell and Immunoglobulin G Immune Responses in Oncology Workers following COVID-19 Vaccination: An Interim Analysis of a Prospective Cohort Study
We conducted a prospective study to evaluate immune responses to SARS-CoV-2 in oncology workers in which we collected blood and clinical data every 6 months. Spike-specific CD4(+) T-cells and immunoglobulin G responses were measured using interferon-gamma enzyme-linked immunosorbent spot and enzyme-...
Autores principales: | Gallen, Corey, Dukes, Christopher W., Aldrich, Amy, Macaisa, Lauren, Mo, Qianxing, Cubitt, Christopher L., Pilon-Thomas, Shari, Giuliano, Anna R., Czerniecki, Brian J., Costa, Ricardo L. B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9696551/ https://www.ncbi.nlm.nih.gov/pubmed/36423026 http://dx.doi.org/10.3390/vaccines10111931 |
Ejemplares similares
-
Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023) -
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
por: Giuliano, Anna R., et al.
Publicado: (2022) -
SARS-CoV-2 antibody response duration and neutralization following natural infection
por: Dukes, Christopher W, et al.
Publicado: (2023) -
Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway
por: Jia, Yongsheng, et al.
Publicado: (2021) -
Differentiation and Regulation of T(H) Cells: A Balancing Act for Cancer Immunotherapy
por: Basu, Amrita, et al.
Publicado: (2021)